About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals In-Silico Drug Discovery Market Size, Share, Growth, Report to 2030
In-Silico Drug Discovery Market

In-Silico Drug Discovery Market Size, Share & Trends Analysis Report Based on Product (Software, Software-as-a-Service, Consultancy-as-a-Service), Based on Workflow (Discovery, Pre-Clinical Tests, Clinical Tests), Based on Technology (Artificial Intelligence), Based on Target Therapeutic Area (HIV, Infectious diseases, Metabolic disorders, Mental disorders, Musculoskeletal disorders, Neurological disorders, Oncological disorders, Respiratory disorders, Skin disorders, Urogenital disorders, Autoimmune disorders, Blood disorders, Cardiovascular disorders, Gastrointestinal and digestive disorders, hormonal disorders, and others.), Based on End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRPH1988DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global In-Silico Drug Discovery Market Introduction
    2. Based on Product
      1. Introduction
        1. Based on Product By Value
      2. Software
        1. By Value
      3. Software-as-a-Service
        1. By Value
      4. Consultancy-as-a-Service
        1. By Value
    3. Based on Workflow
      1. Introduction
        1. Based on Workflow By Value
      2. Discovery
        1. By Value
      3. Pre-Clinical Tests
        1. By Value
      4. Clinical Tests
        1. By Value
    4. Based on Technology
      1. Introduction
        1. Based on Technology By Value
      2. Artificial Intelligence
        1. By Value
    5. Based on Target Therapeutic Area
      1. Introduction
        1. Based on Target Therapeutic Area By Value
      2. HIV
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Metabolic disorders
        1. By Value
      5. Mental disorders
        1. By Value
      6. Musculoskeletal disorders
        1. By Value
      7. Neurological disorders
        1. By Value
      8. Oncological disorders
        1. By Value
      9. Respiratory disorders
        1. By Value
      10. Skin disorders
        1. By Value
      11. Urogenital disorders
        1. By Value
      12. Autoimmune disorders
        1. By Value
      13. Blood disorders
        1. By Value
      14. Cardiovascular disorders
        1. By Value
      15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
        1. By Value
    6. Based on End-User
      1. Introduction
        1. Based on End-User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Contract Research Organizations
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    1. Introduction
    2. Based on Product
      1. Introduction
        1. Based on Product By Value
      2. Software
        1. By Value
      3. Software-as-a-Service
        1. By Value
      4. Consultancy-as-a-Service
        1. By Value
    3. Based on Workflow
      1. Introduction
        1. Based on Workflow By Value
      2. Discovery
        1. By Value
      3. Pre-Clinical Tests
        1. By Value
      4. Clinical Tests
        1. By Value
    4. Based on Technology
      1. Introduction
        1. Based on Technology By Value
      2. Artificial Intelligence
        1. By Value
    5. Based on Target Therapeutic Area
      1. Introduction
        1. Based on Target Therapeutic Area By Value
      2. HIV
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Metabolic disorders
        1. By Value
      5. Mental disorders
        1. By Value
      6. Musculoskeletal disorders
        1. By Value
      7. Neurological disorders
        1. By Value
      8. Oncological disorders
        1. By Value
      9. Respiratory disorders
        1. By Value
      10. Skin disorders
        1. By Value
      11. Urogenital disorders
        1. By Value
      12. Autoimmune disorders
        1. By Value
      13. Blood disorders
        1. By Value
      14. Cardiovascular disorders
        1. By Value
      15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
        1. By Value
    6. Based on End-User
      1. Introduction
        1. Based on End-User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Contract Research Organizations
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    7. U.S.
      1. Based on Product
        1. Introduction
          1. Based on Product By Value
        2. Software
          1. By Value
        3. Software-as-a-Service
          1. By Value
        4. Consultancy-as-a-Service
          1. By Value
      2. Based on Workflow
        1. Introduction
          1. Based on Workflow By Value
        2. Discovery
          1. By Value
        3. Pre-Clinical Tests
          1. By Value
        4. Clinical Tests
          1. By Value
      3. Based on Technology
        1. Introduction
          1. Based on Technology By Value
        2. Artificial Intelligence
          1. By Value
      4. Based on Target Therapeutic Area
        1. Introduction
          1. Based on Target Therapeutic Area By Value
        2. HIV
          1. By Value
        3. Infectious diseases
          1. By Value
        4. Metabolic disorders
          1. By Value
        5. Mental disorders
          1. By Value
        6. Musculoskeletal disorders
          1. By Value
        7. Neurological disorders
          1. By Value
        8. Oncological disorders
          1. By Value
        9. Respiratory disorders
          1. By Value
        10. Skin disorders
          1. By Value
        11. Urogenital disorders
          1. By Value
        12. Autoimmune disorders
          1. By Value
        13. Blood disorders
          1. By Value
        14. Cardiovascular disorders
          1. By Value
        15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
          1. By Value
      5. Based on End-User
        1. Introduction
          1. Based on End-User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Contract Research Organizations
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    8. Canada
    1. Introduction
    2. Based on Product
      1. Introduction
        1. Based on Product By Value
      2. Software
        1. By Value
      3. Software-as-a-Service
        1. By Value
      4. Consultancy-as-a-Service
        1. By Value
    3. Based on Workflow
      1. Introduction
        1. Based on Workflow By Value
      2. Discovery
        1. By Value
      3. Pre-Clinical Tests
        1. By Value
      4. Clinical Tests
        1. By Value
    4. Based on Technology
      1. Introduction
        1. Based on Technology By Value
      2. Artificial Intelligence
        1. By Value
    5. Based on Target Therapeutic Area
      1. Introduction
        1. Based on Target Therapeutic Area By Value
      2. HIV
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Metabolic disorders
        1. By Value
      5. Mental disorders
        1. By Value
      6. Musculoskeletal disorders
        1. By Value
      7. Neurological disorders
        1. By Value
      8. Oncological disorders
        1. By Value
      9. Respiratory disorders
        1. By Value
      10. Skin disorders
        1. By Value
      11. Urogenital disorders
        1. By Value
      12. Autoimmune disorders
        1. By Value
      13. Blood disorders
        1. By Value
      14. Cardiovascular disorders
        1. By Value
      15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
        1. By Value
    6. Based on End-User
      1. Introduction
        1. Based on End-User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Contract Research Organizations
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    7. U.K.
      1. Based on Product
        1. Introduction
          1. Based on Product By Value
        2. Software
          1. By Value
        3. Software-as-a-Service
          1. By Value
        4. Consultancy-as-a-Service
          1. By Value
      2. Based on Workflow
        1. Introduction
          1. Based on Workflow By Value
        2. Discovery
          1. By Value
        3. Pre-Clinical Tests
          1. By Value
        4. Clinical Tests
          1. By Value
      3. Based on Technology
        1. Introduction
          1. Based on Technology By Value
        2. Artificial Intelligence
          1. By Value
      4. Based on Target Therapeutic Area
        1. Introduction
          1. Based on Target Therapeutic Area By Value
        2. HIV
          1. By Value
        3. Infectious diseases
          1. By Value
        4. Metabolic disorders
          1. By Value
        5. Mental disorders
          1. By Value
        6. Musculoskeletal disorders
          1. By Value
        7. Neurological disorders
          1. By Value
        8. Oncological disorders
          1. By Value
        9. Respiratory disorders
          1. By Value
        10. Skin disorders
          1. By Value
        11. Urogenital disorders
          1. By Value
        12. Autoimmune disorders
          1. By Value
        13. Blood disorders
          1. By Value
        14. Cardiovascular disorders
          1. By Value
        15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
          1. By Value
      5. Based on End-User
        1. Introduction
          1. Based on End-User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Contract Research Organizations
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. Based on Product
      1. Introduction
        1. Based on Product By Value
      2. Software
        1. By Value
      3. Software-as-a-Service
        1. By Value
      4. Consultancy-as-a-Service
        1. By Value
    3. Based on Workflow
      1. Introduction
        1. Based on Workflow By Value
      2. Discovery
        1. By Value
      3. Pre-Clinical Tests
        1. By Value
      4. Clinical Tests
        1. By Value
    4. Based on Technology
      1. Introduction
        1. Based on Technology By Value
      2. Artificial Intelligence
        1. By Value
    5. Based on Target Therapeutic Area
      1. Introduction
        1. Based on Target Therapeutic Area By Value
      2. HIV
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Metabolic disorders
        1. By Value
      5. Mental disorders
        1. By Value
      6. Musculoskeletal disorders
        1. By Value
      7. Neurological disorders
        1. By Value
      8. Oncological disorders
        1. By Value
      9. Respiratory disorders
        1. By Value
      10. Skin disorders
        1. By Value
      11. Urogenital disorders
        1. By Value
      12. Autoimmune disorders
        1. By Value
      13. Blood disorders
        1. By Value
      14. Cardiovascular disorders
        1. By Value
      15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
        1. By Value
    6. Based on End-User
      1. Introduction
        1. Based on End-User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Contract Research Organizations
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    7. China
      1. Based on Product
        1. Introduction
          1. Based on Product By Value
        2. Software
          1. By Value
        3. Software-as-a-Service
          1. By Value
        4. Consultancy-as-a-Service
          1. By Value
      2. Based on Workflow
        1. Introduction
          1. Based on Workflow By Value
        2. Discovery
          1. By Value
        3. Pre-Clinical Tests
          1. By Value
        4. Clinical Tests
          1. By Value
      3. Based on Technology
        1. Introduction
          1. Based on Technology By Value
        2. Artificial Intelligence
          1. By Value
      4. Based on Target Therapeutic Area
        1. Introduction
          1. Based on Target Therapeutic Area By Value
        2. HIV
          1. By Value
        3. Infectious diseases
          1. By Value
        4. Metabolic disorders
          1. By Value
        5. Mental disorders
          1. By Value
        6. Musculoskeletal disorders
          1. By Value
        7. Neurological disorders
          1. By Value
        8. Oncological disorders
          1. By Value
        9. Respiratory disorders
          1. By Value
        10. Skin disorders
          1. By Value
        11. Urogenital disorders
          1. By Value
        12. Autoimmune disorders
          1. By Value
        13. Blood disorders
          1. By Value
        14. Cardiovascular disorders
          1. By Value
        15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
          1. By Value
      5. Based on End-User
        1. Introduction
          1. Based on End-User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Contract Research Organizations
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. Based on Product
      1. Introduction
        1. Based on Product By Value
      2. Software
        1. By Value
      3. Software-as-a-Service
        1. By Value
      4. Consultancy-as-a-Service
        1. By Value
    3. Based on Workflow
      1. Introduction
        1. Based on Workflow By Value
      2. Discovery
        1. By Value
      3. Pre-Clinical Tests
        1. By Value
      4. Clinical Tests
        1. By Value
    4. Based on Technology
      1. Introduction
        1. Based on Technology By Value
      2. Artificial Intelligence
        1. By Value
    5. Based on Target Therapeutic Area
      1. Introduction
        1. Based on Target Therapeutic Area By Value
      2. HIV
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Metabolic disorders
        1. By Value
      5. Mental disorders
        1. By Value
      6. Musculoskeletal disorders
        1. By Value
      7. Neurological disorders
        1. By Value
      8. Oncological disorders
        1. By Value
      9. Respiratory disorders
        1. By Value
      10. Skin disorders
        1. By Value
      11. Urogenital disorders
        1. By Value
      12. Autoimmune disorders
        1. By Value
      13. Blood disorders
        1. By Value
      14. Cardiovascular disorders
        1. By Value
      15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
        1. By Value
    6. Based on End-User
      1. Introduction
        1. Based on End-User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Contract Research Organizations
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    7. UAE
      1. Based on Product
        1. Introduction
          1. Based on Product By Value
        2. Software
          1. By Value
        3. Software-as-a-Service
          1. By Value
        4. Consultancy-as-a-Service
          1. By Value
      2. Based on Workflow
        1. Introduction
          1. Based on Workflow By Value
        2. Discovery
          1. By Value
        3. Pre-Clinical Tests
          1. By Value
        4. Clinical Tests
          1. By Value
      3. Based on Technology
        1. Introduction
          1. Based on Technology By Value
        2. Artificial Intelligence
          1. By Value
      4. Based on Target Therapeutic Area
        1. Introduction
          1. Based on Target Therapeutic Area By Value
        2. HIV
          1. By Value
        3. Infectious diseases
          1. By Value
        4. Metabolic disorders
          1. By Value
        5. Mental disorders
          1. By Value
        6. Musculoskeletal disorders
          1. By Value
        7. Neurological disorders
          1. By Value
        8. Oncological disorders
          1. By Value
        9. Respiratory disorders
          1. By Value
        10. Skin disorders
          1. By Value
        11. Urogenital disorders
          1. By Value
        12. Autoimmune disorders
          1. By Value
        13. Blood disorders
          1. By Value
        14. Cardiovascular disorders
          1. By Value
        15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
          1. By Value
      5. Based on End-User
        1. Introduction
          1. Based on End-User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Contract Research Organizations
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. Based on Product
      1. Introduction
        1. Based on Product By Value
      2. Software
        1. By Value
      3. Software-as-a-Service
        1. By Value
      4. Consultancy-as-a-Service
        1. By Value
    3. Based on Workflow
      1. Introduction
        1. Based on Workflow By Value
      2. Discovery
        1. By Value
      3. Pre-Clinical Tests
        1. By Value
      4. Clinical Tests
        1. By Value
    4. Based on Technology
      1. Introduction
        1. Based on Technology By Value
      2. Artificial Intelligence
        1. By Value
    5. Based on Target Therapeutic Area
      1. Introduction
        1. Based on Target Therapeutic Area By Value
      2. HIV
        1. By Value
      3. Infectious diseases
        1. By Value
      4. Metabolic disorders
        1. By Value
      5. Mental disorders
        1. By Value
      6. Musculoskeletal disorders
        1. By Value
      7. Neurological disorders
        1. By Value
      8. Oncological disorders
        1. By Value
      9. Respiratory disorders
        1. By Value
      10. Skin disorders
        1. By Value
      11. Urogenital disorders
        1. By Value
      12. Autoimmune disorders
        1. By Value
      13. Blood disorders
        1. By Value
      14. Cardiovascular disorders
        1. By Value
      15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
        1. By Value
    6. Based on End-User
      1. Introduction
        1. Based on End-User By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Contract Research Organizations
        1. By Value
      4. Academic and Research Institutes
        1. By Value
    7. Brazil
      1. Based on Product
        1. Introduction
          1. Based on Product By Value
        2. Software
          1. By Value
        3. Software-as-a-Service
          1. By Value
        4. Consultancy-as-a-Service
          1. By Value
      2. Based on Workflow
        1. Introduction
          1. Based on Workflow By Value
        2. Discovery
          1. By Value
        3. Pre-Clinical Tests
          1. By Value
        4. Clinical Tests
          1. By Value
      3. Based on Technology
        1. Introduction
          1. Based on Technology By Value
        2. Artificial Intelligence
          1. By Value
      4. Based on Target Therapeutic Area
        1. Introduction
          1. Based on Target Therapeutic Area By Value
        2. HIV
          1. By Value
        3. Infectious diseases
          1. By Value
        4. Metabolic disorders
          1. By Value
        5. Mental disorders
          1. By Value
        6. Musculoskeletal disorders
          1. By Value
        7. Neurological disorders
          1. By Value
        8. Oncological disorders
          1. By Value
        9. Respiratory disorders
          1. By Value
        10. Skin disorders
          1. By Value
        11. Urogenital disorders
          1. By Value
        12. Autoimmune disorders
          1. By Value
        13. Blood disorders
          1. By Value
        14. Cardiovascular disorders
          1. By Value
        15. Gastrointestinal and digestive disorders, hormonal disorders, and others.
          1. By Value
      5. Based on End-User
        1. Introduction
          1. Based on End-User By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Contract Research Organizations
          1. By Value
        4. Academic and Research Institutes
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. In-Silico Drug Discovery Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Albany Molecular Research Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Certara
    3. Charles River Laboratories
    4. Chemical Computing Group ULC
    5. GenScript
    6. LakePharma Inc.
    7. Sygnature Discovery
    8. Abzena Ltd.
    9. BioNTech SE
    10. Creative Biostructure
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Drug Discovery Market Size The global drug discovery market size was valued at USD 24.84 billion in 2024 and is projected to reach from USD 28.98 billion in 2025 to USD 62.10 billion by 2033, growing at a CAGR of 14.90% during the forecast peri
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.